RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 BNP Screening, Targeted Care Reduce Heart Failure in At-Risk Patients
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 2
SP 17
OP 18
DO 10.1177/155989771302009
UL http://mdc.sagepub.com/content/13/2/17.abstract
AB Structured screening for heart failure (HF) using measurement of B-type natriuretic peptide (BNP) followed by targeted collaborative care was effective at preventing left ventricular dysfunction and HF in a community setting. The use of biomarkers related to ventricular damage or dysfunction may improve the ability to identify individuals at risk and ultimately prevent downstream complications. Because it reflects established cardiovascular (CV) insult rather than CV risk, BNP might help identify high risk patients and help focus care where it is needed most, according to the rationale for the St. Vincent's Screening to Prevent Heart Failure study [STOP-HF; NCT00921960].